Literature DB >> 22117133

Occurrence of eye movement disorders in motor neuron disease.

Emilie Beaufils1, Philippe Corcia, Bertrand de Toffol, Julien Praline.   

Abstract

The diagnosis of amyotrophic lateral sclerosis (ALS) relies on symptoms and signs related to upper and lower motor neuron injury. Preservation of normal ocular motor movements is an important criterion for making this diagnosis as oculomotility pathways are classically spared in ALS. However, some authors report eye disturbances resulting from nuclear and supranuclear ophthalmoplegia in autopsy-proven ALS. Here, we report a case in which eye movement disorders were an early sign associated with a bulbar-onset ALS. The association of progressive ophthalmoplegia, dysexecutive syndrome and automatico-voluntary dissociation of eyelid occlusion suggested a 'progressive supranuclear palsy variant' of ALS caused by a disturbance in the descending frontal projections, even though morphological imaging was normal. Motor neuron disease with eye movement disorders must not be considered as a distinct clinical entity and must not exclude a diagnosis of ALS.

Entities:  

Mesh:

Year:  2011        PMID: 22117133     DOI: 10.3109/17482968.2011.580848

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  4 in total

1.  Pathologic correlates of supranuclear gaze palsy with parkinsonism.

Authors:  W R W Martin; J Hartlein; B A Racette; N Cairns; J S Perlmutter
Journal:  Parkinsonism Relat Disord       Date:  2017-02-24       Impact factor: 4.891

2.  Detection of third and sixth cranial nerve palsies with a novel method for eye tracking while watching a short film clip.

Authors:  Uzma Samadani; Sameer Farooq; Robert Ritlop; Floyd Warren; Marleen Reyes; Elizabeth Lamm; Anastasia Alex; Elena Nehrbass; Radek Kolecki; Michael Jureller; Julia Schneider; Agnes Chen; Chen Shi; Neil Mendhiratta; Jason H Huang; Meng Qian; Roy Kwak; Artem Mikheev; Henry Rusinek; Ajax George; Robert Fergus; Douglas Kondziolka; Paul P Huang; R Theodore Smith
Journal:  J Neurosurg       Date:  2014-12-12       Impact factor: 5.115

3.  Microstructural changes across different clinical milestones of disease in amyotrophic lateral sclerosis.

Authors:  Francesca Trojsi; Giuseppina Caiazzo; Daniele Corbo; Giovanni Piccirillo; Viviana Cristillo; Cinzia Femiano; Teresa Ferrantino; Mario Cirillo; Maria Rosaria Monsurrò; Fabrizio Esposito; Gioacchino Tedeschi
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

4.  De novo FUS P525L mutation in Juvenile amyotrophic lateral sclerosis with dysphonia and diplopia.

Authors:  Claire S Leblond; Alina Webber; Ziv Gan-Or; Fraser Moore; Alain Dagher; Patrick A Dion; Guy A Rouleau
Journal:  Neurol Genet       Date:  2016-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.